Janux Therapeutics
JANX
JANX
48 hedge funds and large institutions have $370M invested in Janux Therapeutics in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 22 increasing their positions, 11 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
4% less funds holding
Funds holding: 50 → 48 (-2)
20% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 10
Holders
48
Holding in Top 10
–
Calls
$630K
Puts
$25K
Top Buyers
| 1 | +$40.2M | |
| 2 | +$3.31M | |
| 3 | +$1.92M | |
| 4 |
BlackRock
New York
|
+$526K |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$521K |
Top Sellers
| 1 | -$7.74M | |
| 2 | -$6.13M | |
| 3 | -$5.88M | |
| 4 |
E
Ergoteles
New York
|
-$416K |
| 5 |
PL
Parkwood LLC
Cleveland,
Ohio
|
-$283K |